PureTech Health plc (LON:PRTC)

PureTech Health Statistics

Total Valuation

PureTech Health has a market cap or net worth of GBP 334.94 million. The enterprise value is 266.69 million.

Market Cap	334.94M
Enterprise Value	266.69M

Important Dates

The last earnings date was Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

PureTech Health has 243.42 million shares outstanding. The number of shares has decreased by -5.37% in one year.

Current Share Class	243.42M
Shares Outstanding	243.42M
Shares Change (YoY)	-5.37%
Shares Change (QoQ)	+0.69%
Owned by Insiders (%)	3.56%
Owned by Institutions (%)	75.03%
Float	157.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	96.76
PB Ratio	1.47
P/TBV Ratio	1.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.27
EV / Sales	77.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.22

Financial Position

The company has a current ratio of 6.59, with a Debt / Equity ratio of 0.66.

Current Ratio	6.59
Quick Ratio	6.41
Debt / Equity	0.66
Debt / EBITDA	n/a
Debt / FCF	-2.39
Interest Coverage	-2.15

Financial Efficiency

Return on equity (ROE) is -30.85% and return on invested capital (ROIC) is -44.69%.

Return on Equity (ROE)	-30.85%
Return on Assets (ROA)	-10.82%
Return on Invested Capital (ROIC)	-44.69%
Return on Capital Employed (ROCE)	-20.15%
Weighted Average Cost of Capital (WACC)	11.45%
Revenue Per Employee	61,815
Profits Per Employee	-1.46M
Employee Count	56
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-625,606
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.04% in the last 52 weeks. The beta is 0.79, so PureTech Health's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	+1.04%
50-Day Moving Average	124.56
200-Day Moving Average	126.63
Relative Strength Index (RSI)	58.98
Average Volume (20 Days)	648,642

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PureTech Health had revenue of GBP 3.46 million and -81.54 million in losses. Loss per share was -0.34.

Revenue	3.46M
Gross Profit	-38.48M
Operating Income	-73.12M
Pretax Income	-82.42M
Net Income	-81.54M
EBITDA	-71.94M
EBIT	-73.12M
Loss Per Share	-0.34

Balance Sheet

The company has 214.52 million in cash and 151.02 million in debt, with a net cash position of 63.50 million or 0.26 per share.

Cash & Cash Equivalents	214.52M
Total Debt	151.02M
Net Cash	63.50M
Net Cash Per Share	0.26
Equity (Book Value)	227.12M
Book Value Per Share	0.96
Working Capital	192.22M

Cash Flow

In the last 12 months, operating cash flow was -63.25 million and capital expenditures -4,458, giving a free cash flow of -63.26 million.

Operating Cash Flow	-63.25M
Capital Expenditures	-4,458
Depreciation & Amortization	1.18M
Net Borrowing	-2.66M
Free Cash Flow	-63.26M
FCF Per Share	-0.26

Margins

Gross Margin	n/a
Operating Margin	-2,112.34%
Pretax Margin	-2,380.90%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PureTech Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	5.37%
Shareholder Yield	5.37%
Earnings Yield	-24.34%
FCF Yield	-18.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PureTech Health has an Altman Z-Score of 0.88 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.88
Piotroski F-Score	1